http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2754532-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc33103fafd9d9588fb0e5b1cd2229da |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-708 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-708 |
| filingDate | 2021-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_577b3e84427f63c6824731c50c00618e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ba36387b9d3993da79443bc8286a43a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ade0c9e998d2678b7868053590ff0f63 |
| publicationDate | 2021-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2754532-C1 |
| titleOfInvention | Application of method for administration of sodium salt of 2-methylthio-6-nitro-1,2-4-triazol[5,1-c] -1,2,4-triazin-7-one, dihydrate with antiviral activity, for treatment of coronavirus infection covid-19 |
| abstract | FIELD: medicine. n SUBSTANCE: invention relates to medicine, namely to infectious diseases, and is intended for the treatment of coronavirus infection COVID-19. In treatment of the new coronavirus infection COVID-19, the method of administration of the sodium salt of 2-methylthio-6-nitro-1,2-4-triazol[5,1-c]-1,2,4-triazin-7-one, dihydrate, with antiviral activity, is used. Within five days capsules are taken containing 250 mg of sodium salt of 2-methylthio-6-nitro-1,2-4-triazol[5,1-c]-1,2,4-triazin-7-one, dihydrate, by taking one capsule of riamilovir, containing 250 mg of sodium salt of 2-methylthio-6-nitro-1,2-4-triazol[5,1-c]-1,2,4-triazin-7-one, dihydrate, five times a day with a total dosage of 1250 mg/day. Meanwhile, the time interval between doses of the drug is 3 hours. n EFFECT: invention provides treatment for coronavirus infection COVID-19. n 1 cl, 5 tbl |
| priorityDate | 2021-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 144.